PB 45 of 2011
Amendment Determination under section 84AH of the National Health Act 1953 (2011) (No. 3)
National Health Act 1953
___________________________________________________________________________
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 84AH of the National Health Act 1953.
Dated 16 June 2011
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________
1 Name of Instrument
(1) This Instrument is the Amendment Determination under section 84AH of the National Health Act 1953 (2011) (No.3).
(2) This Instrument may also be cited as PB 45 of 2011.
2 Commencement
This Instrument commences on 1 July 2011.
3 Amendments to PB 58 of 2007
Schedule 1 amends the legislative instrument titled Determination under section 84AH of the National Health Act 1953 (PB 58 of 2007) (as amended).
.
Schedule 1 Amendments
[1] Schedule 1, after entry for Clonazepam in the form Oral liquid 2.5 mg per mL, 10 mL:
omit:
| Clonazepam | Injection 1 mg in 1 mL and 1 mL diluent | Injection |
and substitute in the columns in the order indicated:
| Clonazepam | Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent) | Injection |
[2] Schedule 1, after entry for Cyclosporin in the form Capsule 10 mg:
omit:
| Cyclosporin | Solution concentrate for intravenous infusion 50 mg in 1 mL | Injection |
and substitute in the columns in the order indicated:
| Cyclosporin | Solution concentrate for I.V. infusion 50 mg in 1 mL | Injection |
[3] Schedule 1, after entry for Digoxin:
omit:
| Erythromycin | Powder for intravenous infusion containing 1 g (as lactobionate) | Injection |
and substitute in the columns in the order indicated:
| Erythromycin | Powder for I.V. infusion 1 g (as lactobionate) | Injection |
[4] Schedule 1, after entry for Frusemide
omit:
| Glyceryl trinitrate | Sublingual spray, 400 micrograms per dose | Sublingual |
and substitute in the columns in the order indicated:
| Glyceryl Trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual |
[5] Schedule 1, after entry for Ketoprofen
insert in the columns in the order indicated:
| Lacosamide | Oral solution 15 mg per mL, 200 mL | Oral |
[6] Schedule 1, after entry for Methadone in the form Injection containing methadone hydrochloride 10 mg in 1 mL
omit:
| Metronidazole | Suppository 500 mg, | Rectal |
| Metronidazole | Oral suspension 200 mg (as benzoate) per 5 mL, 100 mL | Oral |
and substitute in the columns in the order indicated:
| Metronidazole | Suppositories 500 mg, 10 | Rectal |
| Metronidazole | Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL | Oral |
[7] Schedule 1, after entry for Naproxen
omit:
| Nevirapine | Oral suspension, 10 mg per mL, 240 mL | Oral |
| Oestradiol | Vaginal tablet, 25 micrograms | Vaginal |
and substitute in the columns in the order indicated:
| Nevirapine | Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL | Oral |
| Oestradiol | Vaginal tablets 25 micrograms, 15 | Vaginal |
[8] Schedule 1, after entry for Paracetamol in the form Tablet 665 mg (modified release)
omit:
| Paracetamol | Suppository 500 mg | Rectal |
| Prochlorperazine | Suppository 15 mg, containing prochlorperazine maleate 25 mg | Rectal |
and substitute in the columns in the order indicated:
| Paracetamol | Suppositories 500 mg, 24 | Rectal |
| Prochlorperazine | Suppositories containing prochlorperazine equivalent to 25 mg prochlorperazine maleate, 5 | Rectal |
[9] Schedule 1, after entry for Terbinafine
omit:
| Tipranavir | Oral solution, 100 mg per mL, 95 mL | Oral |
and substitute in the columns in the order indicated:
| Tipranavir | Oral liquid 100 mg per mL, 95 mL | Oral |
[10] Schedule 1, after entry for Tramadol
omit:
| Valganciclovir | Powder for oral solution, 50 mg per mL, 100 mL | Oral |
| Valproic Acid | Crushable tablet containing sodium valproate 100 mg | Oral |
and substitute in the columns in the order indicated:
| Valganciclovir | Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL | Oral |
| Valproic Acid | Tablet, crushable, containing sodium valproate 100 mg | Oral |
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See http://www.frli.gov.au.